New hope for older leukemia patients: gentler treatment trial seeks to control cancer
NCT ID NCT07153796
Summary
This study is testing whether a drug called blinatumomab, given as an injection under the skin, works well and is safe when combined with a milder form of chemotherapy. It is for older adults (60+) or younger adults who are too frail for standard intensive chemotherapy and have a newly diagnosed type of blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). The main goals are to see if this combination helps patients live longer without their cancer returning and to monitor for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas M. D. Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.